Hepatitis C Screening Update Could Increase Liver Donors

2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients
January 4, 2018
Can Yoga Help Relieve Crohn’s Symptoms? 
January 4, 2018
Show all

Hepatitis C Screening Update Could Increase Liver Donors

Screening tests for hepatitis C could increase the number of liver donors.

An updated approach to screening liver donors for the hepatitis C virus (HCV) could make more organs available for non-infected patients – including grafts from intravenous drug users, new research suggests.

“A liver donor’s hepatitis C status should be defined by NAT testing rather than antibody testing, since it is a more accurate measure of active infection,’’ Khurram Bari, MD, Assistant Professor of Medicine, University of Cincinnati in Ohio, told MD Magazine. 

Nucleic acid testing (NAT) indicates whether a virus is present by detecting and amplifying its RNA or DNA. If the NAT is negative, there’s a much lower risk of HCV transmission. Antibody testing, in comparison, shows that there has been an HCV infection at some point, but does not specifically indicate if the infection is current.

With breakthroughs in HCV treatment and rising rates of intravenous drug use, more donors are HCV antibody-positive but NAT-negative, the researchers noted.

Until now, though, the risk of HCV transmission from the liver grafts of these donors to HCV-negative recipients had not been studied.

“A potential opportunity to expand the donor pool would be through the offering of organs from these individuals, which are otherwise reserved for HCV- infected recipients, to any patient on the transplant waiting-list,” researchers wrote.

Such organs have generally been discarded if an HCV viremic recipient is not available.

Based on data from the Organ Procurement and Transplantation Network (OPTN), between 150 and 200 antibody-positive/NAT-negative liver grafts were available in 2016, Bari said.

To estimate the incidence of HCV transmission from such donors, Bari and his team followed 26 HCV-negative liver transplant recipients. Twenty-five of them were HCV antibody-negative and one was NAT-negative. One of the recipients died 18 days after transplantation.

The patients received a liver graft from donors who were HCV antibody-positive but serum NAT-negative between March 2016 and March 2017.  Fifteen of the donors had died from a drug overdose.

Read full article: Hepatitis C Screening Update Could Increase Liver Donors | MD Magazine

Read Full Article: Hepatitis C Screening Update Could Increase Liver Donors | MD Magazine

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.